LIN-28B Antibody Summary
Immunogen |
This antibody is specific for the C Terminus Region of the target protein.
|
Specificity |
This product is specific for Human LIN28B.
|
Clonality |
Polyclonal
|
Host |
Rabbit
|
Gene |
LIN28B
|
Purity |
Immunogen affinity purified
|
Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
Dilutions |
|
|
Application Notes |
This antibody is useful in ELISA and Western Blot.
|
|
Publications |
|
Reactivity Notes
Human.
Packaging, Storage & Formulations
Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
|
Buffer |
20mM Potassium Phosphate (pH 7.0) and 0.15M NaCl
|
Preservative |
No Preservative
|
Purity |
Immunogen affinity purified
|
Notes
Manufactured by SDIXs proprietary Genomic Antibody Technology. GAT FAQs.
Alternate Names for LIN-28B Antibody
- CSDD2
- CSDD2protein lin-28 homolog B
- FLJ16517
- lin-28 homolog B (C. elegans)
- Lin-28.2
- LIN28B
- LIN-28B
Background
LIN28B acts as a suppressor of microRNA (miRNA) biogenesis by specifically binding the precursor let-7 (pre-let-7), a miRNA precursor. Acts by binding pre-let-7 and recruiting ZCCHC11/TUT4 uridylyltransferase, leading to the terminal uridylation of pre-let-7. Uridylated pre-let-7 miRNAs fail to be processed by Dicer and undergo degradation. Specifically recognizes the 5-GGAG-3 motif in the terminal loop of pre-let-7. Also recognizes and binds non pre-let-7 pre-miRNAs that contain the 5-GGAG-3 motif in the terminal loop, leading to their terminal uridylation and subsequent degradation. Mediates MYC-mediated let-7 repression. Isoform 1, when overexpressed, stimulates growth of the breast adenocarcinoma cell line MCF-7. Isoform 2 has no effect on cell growth.